In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology), By Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Occular Toxicity, Others), By Method (Cellular Assay, Biochemical Assay, In-Silico, Ex-Vivo), By

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology), By Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Occular Toxicity, Others), By Method (Cellular Assay, Biochemical Assay, In-Silico, Ex-Vivo), By

Forecast Period 2024-2028
Market Size (2022) USD 16.09 billion
CAGR (2023-2028) 9.66%
Fastest Growing Segment Cell Culture Technology
Largest Market North-America

MIR Animal Healthcare

Download Sample  Ask for Discount  Request Customization 

Market Overview

Global In-vitro Toxicology Testing Market has valued at USD 16.09 Billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 9.66% through 2028.

In-vitro Toxicology Testing are the scientific process of evaluating the potential toxic effects of various substances on biological systems outside of a living organism, typically in a laboratory setting. The term "in vitro" is Latin for "in glass," and it signifies experiments conducted in a controlled environment such as test tubes, culture dishes, or other artificial systems rather than in a whole living organism (in vivo). They are utilized to assess the safety of chemicals, drugs, cosmetics, consumer products, and other substances without subjecting animals or humans to potentially harmful effects. These tests provide valuable insights into the potential risks and effects of substances on cellular, molecular, and biochemical levels. In-vitro testing is also often used to screen and prioritize substances for further testing in animal models or clinical trials. In-vitro toxicology testing has several advantages over traditional animal testing, including ethical considerations, reduced cost and time, and potential for high-throughput screening. However, it also has limitations, such as the inability to fully replicate the complexity of whole organisms and potential differences in responses between in-vitro systems and living organisms. In-vitro Toxicology Testing can be categorized based on cell culture assays, Enzyme Assays, Genotoxicity Assays, Cytotoxicity Assays and High-Throughput Screening (HTS) In-vitro Toxicology Testing.

Key Market Drivers

Rising Demand For Safety Assessment Of New Drugs And Chemicals

The rising demand for safety assessment of new drugs and chemicals is a significant driver for the growth of the global in-vitro toxicology testing market. This demand is influenced by several factors that highlight the importance of in-vitro testing methods in ensuring the safety and efficacy of pharmaceuticals, chemicals, and other products.

Advances In In-Vitro Toxicology Technologies Propels the Market Growth

Advances in in-vitro toxicology technologies play a crucial role in driving the growth of the global in-vitro toxicology testing market. These technological advancements enhance the accuracy, efficiency, and predictive capabilities of in-vitro testing methods, making them more attractive and valuable for various industries.

MIR Segment1

Download Sample  Ask for Discount  Request Customization 

Increased Awareness Of The Importance Of Safety Testing Drives the Market Growth

Increased awareness of the importance of safety testing plays a significant role in driving the growth of the global in-vitro toxicology testing market. As stakeholders across industries become more informed about the benefits and necessity of rigorous safety assessments, the demand for in-vitro testing methods rises. Growing awareness of animal welfare and ethical concerns associated with traditional animal testing methods has led to increased demand for alternative approaches, such as in-vitro testing. Stakeholders are increasingly recognizing the need for humane and more socially responsible testing methods. Consumer awareness and concerns about the safety of products they use, including pharmaceuticals, cosmetics, and food additives, are driving demand for more thorough safety assessments. In-vitro toxicology testing provides a reliable means to evaluate potential risks and ensure consumer safety. Media coverage and advocacy campaigns focusing on the potential hazards of certain chemicals and substances have heightened public awareness of the importance of safety testing. This increased attention encourages regulatory agencies, industries, and researchers to prioritize safety assessments using advanced methods like in-vitro testing. Regulatory agencies worldwide are emphasizing the importance of comprehensive safety testing for new compounds before they are approved for commercial use. Increased awareness of regulatory guidelines and requirements prompts industries to invest in advanced testing methods like in-vitro toxicology. Greater awareness of environmental impacts and ecological considerations related to chemical exposure fuels the demand for in-vitro testing methods that can assess both human health and environmental safety.

Download Free Sample Report

Key Market Challenges

Complexity of Biological Systems

The complexity of biological systems poses significant challenges to the global in-vitro toxicity testing market. While in-vitro methods offer numerous advantages, accurately replicating the intricate interactions and dynamic processes that occur within living organisms is a complex endeavor. The challenges arising from biological complexity impact the predictive accuracy, relevance, and applicability of in-vitro toxicity testing. In-vitro models often focus on individual cell types or simplified tissues, which fail to capture the interactions between different organs, tissues, and cell types that occur in the whole organism. This limitation reduces the ability to predict systemic effects and complex physiological responses. Cells in the body interact within a specific microenvironment, including extracellular matrix, signaling molecules, and neighboring cells. Replicating these interactions in in-vitro models is challenging, potentially leading to altered cellular behavior and responses.

Limited Relevance for Some Endpoints

The limited relevance of some endpoints in in-vitro toxicity testing poses challenges to the global market. While in-vitro methods offer valuable insights into many aspects of toxicity, there are certain complex and multifaceted toxicological endpoints that may not be well-captured by these models. This limitation affects the ability of in-vitro testing to fully replace traditional animal testing and impacts its application in certain regulatory and research contexts. Some toxicological effects, such as immune responses, hormonal regulation, and organ-specific toxicities, involve intricate interactions between various cell types, tissues, and physiological processes. In-vitro models often cannot fully replicate these complex mechanisms. Chronic toxicity and long-term effects, such as carcinogenicity and reproductive toxicity, are challenging to assess in short-term in-vitro assays. These endpoints require a comprehensive understanding of how substances interact with the body over extended periods, which is difficult to capture in simplified in-vitro systems. Many toxicological responses involve the integration of multiple pathways and processes. In-vitro models may not fully capture the synergistic or cumulative effects that occur in vivo.

MIR Regional

Download Sample  Ask for Discount  Request Customization 

Long-Term and Chronic Effects

Assessing long-term and chronic effects poses significant challenges to the global in-vitro toxicity testing market. In-vitro methods are often designed for short-term experiments and may not fully capture the complex and dynamic nature of chronic exposures and their associated effects. This limitation affects the ability of in-vitro testing to predict and assess the long-term impact of substances, especially in contexts such as chronic diseases, carcinogenicity, and reproductive toxicity. In-vitro assays are typically conducted over short time frames, which may not be sufficient to observe and understand time-dependent processes that occur in chronic exposures, such as accumulation of damage or gradual development of adverse effects. Chronic exposures can lead to cumulative effects over time, which are difficult to replicate in short-term in-vitro experiments. These cumulative effects may result from repeated exposures, metabolic processes, or progressive damage to cellular components.

Key Market Trends

Personalized Medicine Applications

Personalized medicine applications represent a significant trend in the global in-vitro toxicity testing market. Personalized medicine aims to tailor medical treatment to the individual characteristics of each patient, including their genetic makeup, lifestyle, and environmental factors. In the context of in-vitro toxicity testing, personalized medicine applications involve assessing how an individual's unique genetic and physiological characteristics influence their response to potential toxicants. In-vitro toxicity testing can be used to evaluate how a patient's specific genetic and molecular profile influences their susceptibility to adverse effects from chemicals and drugs. This approach enables more accurate and personalized risk assessments, helping to identify individuals who may be particularly sensitive to certain substances. By using patient-derived cells or tissues, researchers can conduct in-vitro toxicity testing to predict how an individual's body might respond to a particular compound. This information can guide treatment decisions and drug choices to maximize efficacy and minimize risks for each patient. In-vitro toxicity testing can help identify biomarkers or specific molecular indicators that signal potential toxic responses in certain individuals. These biomarkers can be used to monitor and predict toxicity in real-time during treatment. In-vitro toxicity testing can play a crucial role in identifying compounds that may lead to adverse reactions in specific patient populations. By selecting safer alternatives based on personalized testing, the risk of adverse effects can be significantly reduced.

Segmental Insights

Technology

In 2022, the In-vitro Toxicology Testing market was dominated by the reactive Cell Culture Technology and is predicted to continue expanding over the coming years. Cell culture technology is a highly accurate and reliable method for toxicity testing. This is because cells can be grown in a controlled environment and can be exposed to a variety of toxicants.

Application Insights

In 2022, the In-vitro Toxicology Testing market was dominated by systemic toxicology segment and is predicted to continue expanding over the coming years. Regulatory agencies require comprehensive safety assessments of chemicals, pharmaceuticals, and consumer products to ensure human health and environmental safety. Systemic toxicity testing is a crucial aspect of these assessments, as it provides valuable information about the potential adverse effects of substances on different organs and systems.

Method Insight

In 2022, the In-vitro Toxicology Testing market was dominated by cellular assay segment and is predicted to continue expanding over the coming years.

End-User Insight

In 2022, the In-vitro Toxicology Testing market was dominated by pharmaceutical industry segment and is predicted to continue expanding over the coming years. The pharmaceutical industry is constantly developing new drugs to treat a variety of diseases. In-vitro toxicity testing is used to assess the safety of these drugs before they are tested in humans.

Download Free Sample Report

Regional Insights

The North America region has established itself as the leader in the Global In-vitro Toxicology Testing Market. The pharmaceutical industry in North America is one of the most advanced and productive in the world. This is driving the demand for in-vitro toxicity testing to assess the safety of new drugs. Regulatory agencies in North America, such as the U.S. Food and Drug Administration (FDA), require the use of in-vitro toxicity testing for the safety assessment of new drugs. This is to ensure that these drugs are safe for human use. There have been significant advances in in-vitro toxicity technologies in recent years. These advances have made it possible to develop more accurate and reliable tests that can be used to assess the safety of new drugs.

Recent Developments

  • In August2023, The Charles River laboratories international,Inc. (CRL) announced today the scheduled opening of the Charles Riveraccelerator and development lab, Charles River Accelerator®, in Seattle andPhiladelphia. Charles River Accelerator® Seattle is Charles River’s latestinvestment in Seattle. The company’s first facility opened in 2021 in responseto the rapidly expanding city’s position as a leading life sciences center withstrong start-up and business growth. CRADL® Seattle is set to open thisSeptember and responds to the growing demand for more dynamic vivarium space,as well as in vivo on-demand study support services. As a leading contractvivarium provider, Charles River Laboratories International (CRL) is committedto expanding the capacity of its biopharmaceutical facilities to meet thegrowing demands of the industry.
  • In August2021, Sidebar Image Pete Coody Dr. Martin Cole Partnering with ERSS Laboratoryin Hercules, North America Center of Testing Excellence Hercules, North AmericaErosion and Radioactivity (E&O) Testing Erosion Detection and Reactivation(EDR) Environmental Fate & Metabolism Testing.
  • In August2023, Evotec, a clinical phase biotechnology company, today announced that itis partnering with the world’s leading small molecule RNA modifying enzyme(RME) drug discovery company (STORM) to present the discovery of STORM’s leadclinical candidate (STC-15) at its Fall 2023 conference (ACS). “STC-15” wasco-developed and developed by Evotec and STORM, a company focused on thediscovery and development of novel small molecule therapeutics (NMTs) focusedon oncology (cancer) and other diseases. STC-15 is a highly selective, orallybioavailable, and RME inhibitor for METTL3.

Key Market Players

  • CharlesRiver Laboratories International, Inc.
  • SGSS.A.
  • MerckKGaA
  • EurofinsScientific
  • AbbottLaboratories
  • LaboratoryCorporation of America Holdings
  • EvotecS.E.
  • ThermoFisher Scientific, Inc.
  • QuestDiagnostics Incorporated
  • AgilentTechnologies, Inc. 

 By Technology

By Application

By Region
  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology
  • Systemic Toxicology
  • Dermal Toxicity
  • Endocrine Disruption
  • Occular Toxicity
  • Others

North America

Europe

Asia Pacific

South America

Middle East & Africa

Table of Content

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation and Scope
                      1.2. Market Definitions
                      1.3. Research Methodology
                      1.4. Information Procurement
                          1.4.1. Purchased Database
                          1.4.2. GVR’s Internal Database
                      1.5. Details of primary research
                          1.5.1. Data for primary interviews in North America
                          1.5.2. Data for primary interviews in Europe
                          1.5.3. Data for primary interviews in Asia Pacific
                          1.5.4. Data for primary interviews in Latin America
                          1.5.5. Data for Primary interviews in MEA
                      1.6. Market Formulation & Validation
                      1.7. Model Details
                          1.7.1. Commodity flow analysis (Model 1)
                              1.7.1.1. Approach 1: Commodity flow approach
                          1.7.2. Volume price analysis (Model 2)
                              1.7.2.1. Approach 2: Volume price analysis
                      1.8. Research Scope and Assumptions
                          1.8.1. List of Secondary Sources
                          1.8.2. List of Primary Sources
                          1.8.3. Objectives
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                      2.3. Competitive Insights
Chapter 3. In-vitro Toxicology Testing Market Variables, Trends, & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent Market Outlook
                          3.1.2. Related/Ancillary Market Outlook
                      3.2. Market Dynamics
                          3.2.1. Market Drivers Analysis
                              3.2.1.1. Rise in government funding for toxicology research
                              3.2.1.2. Opposition in animal testing
                              3.2.1.3. Ongoing developments in advanced toxicology research
                          3.2.2. Market Restraints Analysis
                              3.2.2.1. Lack of in-vitro models
                              3.2.2.2. Issues pertaining to standardization of in vitro studies
                      3.3. In-vitro Toxicology Testing Market Analysis Tools
                          3.3.1. Porter’s Analysis
                              3.3.1.1. Bargaining power of the suppliers
                              3.3.1.2. Bargaining power of the buyers
                              3.3.1.3. Threats of substitution
                              3.3.1.4. Threats from new entrants
                              3.3.1.5. Competitive rivalry
                          3.3.2. PESTEL Analysis
                              3.3.2.1. Political landscape
                              3.3.2.2. Economic and Social landscape
                              3.3.2.3. Technological landscape
                              3.3.2.4. Environmental landscape
                              3.3.2.5. Legal landscape
                          3.3.3. Pricing Analysis
Chapter 4. In-vitro Toxicology Testing Market: Technology Estimates & Trend Analysis
                      4.1. Segment Dashboard
                      4.2. In-vitro Toxicology Testing Market: Technology Movement Analysis, USD Million, 2023 & 2030
                      4.3. Cell Culture Technology
                          4.3.1. Cell Culture Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      4.4. High Throughput Technology
                          4.4.1. High Throughput Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      4.5. Molecular Imaging
                          4.5.1. Molecular Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      4.6. OMICS Technology
                          4.6.1. OMICS Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. In-vitro Toxicology Testing Market: Product Estimates & Trend Analysis
                      5.1. Segment Dashboard
                      5.2. In-vitro Toxicology Testing Market: Product Movement Analysis, USD Million, 2023 & 2030
                      5.3. Consumables
                          5.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      5.4. Assays
                          5.4.1. Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      5.5. Instruments
                          5.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      5.6. Software
                          5.6.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      5.7. Services
                          5.7.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. In-vitro Toxicology Testing Market: Application Estimates & Trend Analysis
                      6.1. Segment Dashboard
                      6.2. In-vitro Toxicology Testing Market: Application Movement Analysis, USD Million, 2023 & 2030
                      6.3. Systemic Toxicology
                          6.3.1. Systemic Toxicology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.3.1.1. Acute Toxicity
                                  6.3.1.1.1. Acute Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.3.1.2. Carcinogenicity
                                  6.3.1.2.1. Carcinogenicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.3.1.3. Developmental Toxicity
                                  6.3.1.3.1. Developmental Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.3.1.4. Others
                                  6.3.1.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      6.4. Dermal Toxicity
                          6.4.1. Dermal Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.4.1.1. Skin Irritation Test
                                  6.4.1.1.1. Skin Irritation Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.4.1.2. Skin Sensitization Test
                                  6.4.1.2.1. Skin Sensitization Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.4.1.3. Skin Corrosion Test
                                  6.4.1.3.1. Skin Corrosion Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.4.1.4. Phototoxicity Test
                                  6.4.1.4.1. Phototoxicity Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.4.1.5. Others
                                  6.4.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      6.5. Endocrine Disruption
                          6.5.1. Endocrine Disruption Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.5.1.1. Dioxins
                                  6.5.1.1.1. Dioxins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.5.1.2. Phthalates
                                  6.5.1.2.1. Phthalates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.5.1.3. Polychlorinated biphenyls (PCB)
                                  6.5.1.3.1. Polychlorinated biphenyls (PCB) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      6.6. Ocular Toxicity
                          6.6.1. Ocular Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.6.1.1. Intravitreal
                                  6.6.1.1.1. Intravitreal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.6.1.2. Subretinal
                                  6.6.1.2.1. Subretinal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.6.1.3. Others
                                  6.6.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      6.7. Other Toxicity
                              6.7.1.1. Other Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.7.1.2. Immunotoxicity
                                  6.7.1.2.1. Immunotoxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.7.1.3. Reproductive Toxicity
                                  6.7.1.3.1. Reproductive Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.7.1.4. Neurotoxicity
                                  6.7.1.4.1. Neurotoxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.7.1.5. Epigenetic Alterations
                                  6.7.1.5.1. Epigenetic Alterations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.7.1.6. Genotoxicity
                                  6.7.1.6.1. Genotoxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              6.7.1.7. Others
                                  6.7.1.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. In-vitro Toxicology Testing Market: Method Estimates & Trend Analysis
                      7.1. Segment Dashboard
                      7.2. In-vitro Toxicology Testing Market: Method Movement Analysis, USD Million, 2023 & 2030
                      7.3. Cellular Assay
                          7.3.1. Cellular Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              7.3.1.1. Live Cells
                                  7.3.1.1.1. Live Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                      7.3.1.1.1.1. High Throughput / High Content Screening
                                          7.3.1.1.1.1.1. High Throughput / High Content Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                      7.3.1.1.1.2. Molecular Imaging
                                          7.3.1.1.1.2.1. Molecular Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                              7.3.1.1.1.2.1.1. Confocal Microscopy
                                                   7.3.1.1.1.2.1.1.1. Confocal Microscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                               7.3.1.1.1.2.1.2. Others
                                                   7.3.1.1.1.2.1.2.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                      7.3.1.1.1.3. Others
                                          7.3.1.1.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              7.3.1.2. Fixed Cells
                                  7.3.1.2.1. Fixed Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      7.4. Biochemical Assay
                          7.4.1. Biochemical Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      7.5. In-silico
                          7.5.1. In-silico Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      7.6. Ex-vivo
                          7.6.1. Ex-vivo Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. In-vitro Toxicology Testing Market: End-Use Estimates & Trend Analysis
                      8.1. Segment Dashboard
                      8.2. In-vitro Toxicology Testing Market: End-Use Movement Analysis, USD Million, 2023 & 2030
                      8.3. Pharmaceutical Industry
                          8.3.1. Pharmaceutical Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      8.4. Cosmetics & Household Products
                          8.4.1. Cosmetics & Household Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      8.5. Academic Institutes & Research Laboratories
                          8.5.1. Academic Institutes & Research Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      8.6. Diagnostics
                          8.6.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              8.6.1.1. Medical Devices
                                  8.6.1.1.1. Medical Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                              8.6.1.2. Others
                                  8.6.1.2.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      8.7. Chemicals Industry
                          8.7.1. Chemicals Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                      8.8. Food Industry
                          8.8.1. Food Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. In-vitro Toxicology Testing Market: Regional Estimates & Trend Analysis
                      9.1. In-vitro Toxicology Testing Market Share, By Region, 2023 & 2030, USD Million
                      9.2. North America
                          9.2.1. North America In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.2.2. U.S.
                              9.2.2.1. Key Country Dynamics
                              9.2.2.2. Regulatory Landscape/Reimbursement Scenario
                              9.2.2.3. Competitive Insights
                              9.2.2.4. U.S. In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.2.3. Canada
                              9.2.3.1. Key Country Dynamics
                              9.2.3.2. Regulatory Landscape/Reimbursement Scenario
                              9.2.3.3. Competitive Insights
                              9.2.3.4. Canada In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                      9.3. Europe
                          9.3.1. Europe In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.3.2. UK
                              9.3.2.1. Key Country Dynamics
                              9.3.2.2. Regulatory Landscape/Reimbursement Scenario
                              9.3.2.3. Competitive Insights
                              9.3.2.4. UK In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.3.3. Germany
                              9.3.3.1. Key Country Dynamics
                              9.3.3.2. Regulatory Landscape/Reimbursement Scenario
                              9.3.3.3. Competitive Insights
                              9.3.3.4. Germany In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.3.4. France
                              9.3.4.1. Key Country Dynamics
                              9.3.4.2. Regulatory Landscape/Reimbursement Scenario
                              9.3.4.3. Competitive Insights
                              9.3.4.4. France In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.3.5. Italy
                              9.3.5.1. Key Country Dynamics
                              9.3.5.2. Regulatory Landscape/Reimbursement Scenario
                              9.3.5.3. Competitive Insights
                              9.3.5.4. Italy In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.3.6. Spain
                              9.3.6.1. Key Country Dynamics
                              9.3.6.2. Regulatory Landscape/Reimbursement Scenario
                              9.3.6.3. Competitive Insights
                              9.3.6.4. Spain In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.3.7. Sweden
                              9.3.7.1. Key Country Dynamics
                              9.3.7.2. Regulatory Landscape/Reimbursement Scenario
                              9.3.7.3. Competitive Insights
                              9.3.7.4. Sweden In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.3.8. Denmark
                              9.3.8.1. Key Country Dynamics
                              9.3.8.2. Regulatory Landscape/Reimbursement Scenario
                              9.3.8.3. Competitive Insights
                              9.3.8.4. Denmark In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.3.9. Norway
                              9.3.9.1. Key Country Dynamics
                              9.3.9.2. Regulatory Landscape/Reimbursement Scenario
                              9.3.9.3. Competitive Insights
                              9.3.9.4. Norway In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                      9.4. Asia Pacific
                          9.4.1. Asia Pacific In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.4.2. China
                              9.4.2.1. Key Country Dynamics
                              9.4.2.2. Regulatory Landscape/Reimbursement Scenario
                              9.4.2.3. Competitive Insights
                              9.4.2.4. China In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.4.3. Japan
                              9.4.3.1. Key Country Dynamics
                              9.4.3.2. Regulatory Landscape/Reimbursement Scenario
                              9.4.3.3. Competitive Insights
                              9.4.3.4. Japan In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.4.4. India
                              9.4.4.1. Key Country Dynamics
                              9.4.4.2. Regulatory Landscape/Reimbursement Scenario
                              9.4.4.3. Competitive Insights
                              9.4.4.4. India In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.4.5. South Korea
                              9.4.5.1. Key Country Dynamics
                              9.4.5.2. Regulatory Landscape/Reimbursement Scenario
                              9.4.5.3. Competitive Insights
                              9.4.5.4. South Korea In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.4.6. Australia
                              9.4.6.1. Key Country Dynamics
                              9.4.6.2. Regulatory Landscape/Reimbursement Scenario
                              9.4.6.3. Competitive Insights
                              9.4.6.4. Australia In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.4.7. Thailand
                              9.4.7.1. Key Country Dynamics
                              9.4.7.2. Regulatory Landscape/Reimbursement Scenario
                              9.4.7.3. Competitive Insights
                              9.4.7.4. Thailand In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                      9.5. Latin America
                          9.5.1. Latin America In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.5.2. Brazil
                              9.5.2.1. Key Country Dynamics
                              9.5.2.2. Regulatory Landscape/Reimbursement Scenario
                              9.5.2.3. Competitive Insights
                              9.5.2.4. Brazil In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.5.3. Mexico
                              9.5.3.1. Key Country Dynamics
                              9.5.3.2. Regulatory Landscape/Reimbursement Scenario
                              9.5.3.3. Competitive Insights
                              9.5.3.4. Mexico In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.5.4. Argentina
                              9.5.4.1. Key Country Dynamics
                              9.5.4.2. Regulatory Landscape/Reimbursement Scenario
                              9.5.4.3. Competitive Insights
                              9.5.4.4. Argentina In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                      9.6. Middle East and Africa
                          9.6.1. Middle East and Africa In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.6.2. Saudi Arabia
                              9.6.2.1. Key Country Dynamics
                              9.6.2.2. Regulatory Landscape/Reimbursement Scenario
                              9.6.2.3. Competitive Insights
                              9.6.2.4. Saudi Arabia In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.6.3. UAE
                              9.6.3.1. Key Country Dynamics
                              9.6.3.2. Regulatory Landscape/Reimbursement Scenario
                              9.6.3.3. Competitive Insights
                              9.6.3.4. UAE In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.6.4. South Africa
                              9.6.4.1. Key Country Dynamics
                              9.6.4.2. Regulatory Landscape/Reimbursement Scenario
                              9.6.4.3. Competitive Insights
                              9.6.4.4. South Africa In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                          9.6.5. Kuwait
                              9.6.5.1. Key Country Dynamics
                              9.6.5.2. Regulatory Landscape/Reimbursement Scenario
                              9.6.5.3. Competitive Insights
                              9.6.5.4. Kuwait In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                      10.1. Recent Developments & Impact Analysis by Key Market Participants
                      10.2. Company Categorization
                      10.3. Company Market Share Analysis, 2023
                      10.4. Company Heat Map Analysis
                      10.5. Strategy Mapping
                          10.5.1. Expansion
                          10.5.2. Mergers & Acquisition
                          10.5.3. Partnerships & Collaborations
                          10.5.4. New Product Launches
                          10.5.5. Research And Development
                      10.6. Company Profiles
                          10.6.1. Charles River Laboratories International, Inc
                              10.6.1.1. Participant’s Overview
                              10.6.1.2. Financial Performance
                              10.6.1.3. Product Benchmarking
                              10.6.1.4. Recent Developments
                          10.6.2. SGS S.A
                              10.6.2.1. Participant’s Overview
                              10.6.2.2. Financial Performance
                              10.6.2.3. Product Benchmarking
                              10.6.2.4. Recent Developments
                          10.6.3. Merck KGaA
                              10.6.3.1. Participant’s Overview
                              10.6.3.2. Financial Performance
                              10.6.3.3. Product Benchmarking
                              10.6.3.4. Recent Developments
                          10.6.4. Eurofins Scientific
                              10.6.4.1. Participant’s Overview
                              10.6.4.2. Financial Performance
                              10.6.4.3. Product Benchmarking
                              10.6.4.4. Recent Developments
                          10.6.5. Abbott Laboratories
                              10.6.5.1. Participant’s Overview
                              10.6.5.2. Financial Performance
                              10.6.5.3. Product Benchmarking
                              10.6.5.4. Recent Developments
                          10.6.6. Laboratory Corporation of America Holdings
                              10.6.6.1. Participant’s Overview
                              10.6.6.2. Financial Performance
                              10.6.6.3. Product Benchmarking
                              10.6.6.4. Recent Developments
                          10.6.7. Evotec S.E
                              10.6.7.1. Participant’s Overview
                              10.6.7.2. Financial Performance
                              10.6.7.3. Product Benchmarking
                              10.6.7.4. Recent Developments
                          10.6.8. Thermo Fisher Scientific, Inc.
                              10.6.8.1. Participant’s Overview
                              10.6.8.2. Financial Performance
                              10.6.8.3. Product Benchmarking
                              10.6.8.4. Recent Developments
                          10.6.9. Quest Diagnostics Incorporated
                              10.6.9.1. Participant’s Overview
                              10.6.9.2. Financial Performance
                              10.6.9.3. Product Benchmarking
                              10.6.9.4. Recent Developments
                          10.6.10. Agilent Technologies, Inc.
                              10.6.10.1. Participant’s Overview
                              10.6.10.2. Financial Performance
                              10.6.10.3. Product Benchmarking
                              10.6.10.4. Recent Developments
                          10.6.11. Catalent, Inc.
                              10.6.11.1. Participant’s Overview
                              10.6.11.2. Financial Performance
                              10.6.11.3. Product Benchmarking
                              10.6.11.4. Recent Developments
                          10.6.12. Danaher
                              10.6.12.1. Participant’s Overview
                              10.6.12.2. Financial Performance
                              10.6.12.3. Product Benchmarking
                              10.6.12.4. Recent Developments
                          10.6.13. Bio-Rad Laboratories, Inc
                              10.6.13.1. Participant’s Overview
                              10.6.13.2. Financial Performance
                              10.6.13.3. Product Benchmarking
                              10.6.13.4. Recent Developments
                          10.6.14. BioIVT
                              10.6.14.1. Participant’s Overview
                              10.6.14.2. Financial Performance
                              10.6.14.3. Product Benchmarking
                              10.6.14.4. Recent Developments
                          10.6.15. Gentronix
                              10.6.15.1. Participant’s Overview
                              10.6.15.2. Financial Performance
                              10.6.15.3. Product Benchmarking
                              10.6.15.4. Recent Developments

 

List of Tables

Table 1 In-vitro toxicology testing market 2018 - 2030 (USD Million)
Table 2 Global market estimates and forecasts by region, 2018 - 2030 (USD Million)
Table 3 Global market estimates and forecasts by product, 2018 - 2030 (USD Million)
Table 4 Global market estimates and forecasts by method, 2018 - 2030 (USD Million)
Table 5 Global market estimates and forecasts by application, 2018 - 2030 (USD Million)
Table 6 Global market estimates and forecasts by technology, 2018 - 2030 (USD Million)
Table 7 Global market estimates and forecasts by end-use, 2018 - 2030 (USD Million)
Table 8 In-vitro toxicology testing- M&A, collaborations & partnership scenario
Table 9 Cell Culture Technology market by region, 2018 - 2030 (USD Million)
Table 10 High Throughput Technology market by region, 2018 - 2030 (USD Million)
Table 11 Molecular Imaging market by region, 2018 - 2030 (USD Million)
Table 12 AI Deep Learning market by region, 2018 - 2030 (USD Million)
Table 13 OMICS Technology market by region, 2018 - 2030 (USD Million)
Table 14 Consumables market by region, 2018 - 2030 (USD Million)
Table 15 Assays market by region, 2018 - 2030 (USD Million)
Table 16 Instruments market by region, 2018 - 2030 (USD Million)
Table 17 Software market by region, 2018 - 2030 (USD Million)
Table 18 Services market by region, 2018 - 2030 (USD Million)
Table 19 Systemic Toxicology market by region, 2018 - 2030 (USD Million)
Table 20 Acute Toxicity market by region, 2018 - 2030 (USD Million)
Table 21 Carcinogenicity market by region, 2018 - 2030 (USD Million)
Table 22 Developmental Toxicity market by region, 2018 - 2030 (USD Million)
Table 23 Others market by region, 2018 - 2030 (USD Million)
Table 24 Dermal Toxicity market by region, 2018 - 2030 (USD Million)
Table 25 Skin Irritation Test market by region, 2018 - 2030 (USD Million)
Table 26 Skin Sensitization Test market by region, 2018 - 2030 (USD Million)
Table 27 Skin Corrosion Test market by region, 2018 - 2030 (USD Million)
Table 28 Phototoxicity Test market by region, 2018 - 2030 (USD Million)
Table 29 Dermal Toxicity market by region, 2018 - 2030 (USD Million)
Table 30 Others market by region, 2018 - 2030 (USD Million)
Table 31 Endocrine Disruption market by region, 2018 - 2030 (USD Million)
Table 32 Dioxins market by region, 2018 - 2030 (USD Million)
Table 33 Skin Sensitization Test market by region, 2018 - 2030 (USD Million)
Table 34 Phthalates market by region, 2018 - 2030 (USD Million)
Table 35 Phototoxicity Test market by region, 2018 - 2030 (USD Million)
Table 36 Polychlorinated biphenyls (PCB) market by region, 2018 - 2030 (USD Million)
Table 37 Occular Toxicity market by region, 2018 - 2030 (USD Million)
Table 38 Intravitreal market by region, 2018 - 2030 (USD Million)
Table 39 Subretinal market by region, 2018 - 2030 (USD Million)
Table 40 Others market by region, 2018 - 2030 (USD Million)
Table 41 Other Toxicity Test market by region, 2018 - 2030 (USD Million)
Table 42 Immunotoxicity market by region, 2018 - 2030 (USD Million)
Table 43 Reproductive Toxicity market by region, 2018 - 2030 (USD Million)
Table 44 Neurotoxicity market by region, 2018 - 2030 (USD Million)
Table 45 Epigenetic Alterations market by region, 2018 - 2030 (USD Million)
Table 46 Genotoxicity market by region, 2018 - 2030 (USD Million)
Table 47 Others market by region, 2018 - 2030 (USD Million)
Table 48 Cellular Assay market by region, 2018 - 2030 (USD Million)
Table 49 Live Cells market by region, 2018 - 2030 (USD Million)
Table 50 High Throughput / High Content Screening market by region, 2018 - 2030 (USD Million)
Table 51 Molecular Imaging market by region, 2018 - 2030 (USD Million)
Table 52 Confocal Microscopy market by region, 2018 - 2030 (USD Million)
Table 53 Others market by region, 2018 - 2030 (USD Million)
Table 54 Biochemical Assay market by region, 2018 - 2030 (USD Million)
Table 55 In-silico market by region, 2018 - 2030 (USD Million)
Table 56 Ex-vivo market by region, 2018 - 2030 (USD Million)
Table 57 Pharmaceutical Industry market by region, 2018 - 2030 (USD Million)
Table 58 Cosmetics & Household Products market by region, 2018 - 2030 (USD Million)
Table 59 Academic Institutes & Research Laboratories market by region, 2018 - 2030 (USD Million)
Table 60 Diagnostics market by region, 2018 - 2030 (USD Million)
Table 61 Medical Devices market by region, 2018 - 2030 (USD Million)
Table 62 Others market by region, 2018 - 2030 (USD Million)
Table 63 Chemicals Industry market by region, 2018 - 2030 (USD Million)
Table 64 Food Industry market by region, 2018 - 2030 (USD Million)
Table 65 North America In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 66 North America In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 67 North America In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 68 North America In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 69 North America In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 70 U.S. In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 71 U.S. In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 72 U.S. In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 73 U.S. In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 74 U.S. In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 75 Canada In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 76 Canada In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 77 Canada In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 78 Canada In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 79 Canada In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 80 Europe In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 81 Europe In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 82 Europe In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 83 Europe In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 84 Europe In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 85 Germany In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 86 Germany In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 87 Germany In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 88 Germany In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 89 Germany In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 90 UK In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 91 UK In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 92 UK In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 93 UK In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 94 UK In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 95 France In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 96 France In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 97 France In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 98 France In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 99 France In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 100 Italy In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 101 Italy In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 102 Italy In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 103 Italy In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 104 Italy In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 105 Spain In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 106 Spain In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 107 Spain In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 108 Spain In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 109 Spain In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 110 Sweden In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 111 Sweden In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 112 Sweden In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 113 Sweden In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 114 Sweden In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 115 Denmark In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 116 Denmark In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 117 Denmark In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 118 Denmark In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 119 Denmark In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 120 Norway In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 121 Norway In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 122 Norway In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 123 Norway In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 124 Norway In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 125 Asia Pacific In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 126 Asia Pacific In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 127 Asia Pacific In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 128 Asia Pacific In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 129 Asia Pacific In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 130 Japan In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 131 Japan In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 132 Japan In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 133 Japan In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 134 Japan In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 135 China In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 136 China In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 137 China In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 138 China In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 139 China In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 140 India In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 141 India In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 142 India In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 143 India In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 144 India In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 145 Australia In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 146 Australia In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 147 Australia In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 148 Australia In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 149 Australia In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 150 South Korea In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 151 South Korea In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 152 South Korea In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 153 South Korea In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 154 South Korea In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 155 Thailand In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 156 Thailand In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 157 Thailand In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 158 Thailand In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 159 Thailand In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 160 Latin America In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 161 Latin America In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 162 Latin America In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 163 Latin America In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 164 Latin America In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 165 Brazil In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 166 Brazil In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 167 Brazil In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 168 Brazil In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 169 Brazil In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 170 Mexico In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 171 Mexico In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 172 Mexico In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 173 Mexico In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 174 Mexico In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 175 Argentina In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 176 Argentina In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 177 Argentina In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 178 Argentina In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 179 Argentina In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 180 Middle East and Africa In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 181 Middle East and Africa In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 182 Middle East and Africa In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 183 Middle East and Africa In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 184 Middle East and Africa In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 185 South Africa In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 186 South Africa In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 187 South Africa In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 188 South Africa In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 189 South Africa In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 190 Saudi Arabia In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 191 Saudi Arabia In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 192 Saudi Arabia In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 193 Saudi Arabia In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 194 Saudi Arabia In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 195 UAE In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 196 UAE In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 197 UAE In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 198 UAE In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
Table 199 UAE In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
Table 200 Kuwait In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
Table 201 Kuwait In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
Table 202 Kuwait In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
Table 203 Kuwait In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
Table 204 Kuwait In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)

 

List of Figures

Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 In-vitro Toxicology Testing, Market Segmentation
Figure 8 Market Snapshot, 2023
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 14 Porter’s Five Forces Analysis
Figure 15 Global In-vitro Toxicology Testing Market: Product Movement Analysis
Figure 16 Global In-vitro Toxicology Testing Market, for Consumables,2018 - 2030, (USD Million)
Figure 17 Global In-vitro Toxicology Testing Market, for Assays,2018 - 2030, (USD Million)
Figure 18 Global In-vitro Toxicology Testing Market, for Instruments,2018 - 2030, (USD Million)
Figure 19 Global In-vitro Toxicology Testing Market, for Software,2018 - 2030, (USD Million)
Figure 20 Global In-vitro Toxicology Testing Market, for Services,2018 - 2030, (USD Million)
Figure 21 Global In-vitro Toxicology Testing Market Market: Application Movement Analysis
Figure 22 Global In-vitro Toxicology Testing Market, for Systemic Toxicology,2018 - 2030, (USD Million)
Figure 23 Global In-vitro Toxicology Testing Market, for Acute Toxicity,2018 - 2030, (USD Million)
Figure 24 Global In-vitro Toxicology Testing Market, for Carcinogenicity,2018 - 2030, (USD Million)
Figure 25 Global In-vitro Toxicology Testing Market, for Developmental Toxicity,2018 - 2030, (USD Million)
Figure 26 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030, (USD Million)
Figure 27 Global In-vitro Toxicology Testing Market, for Dermal Toxicity,2018 - 2030, (USD Million)
Figure 28 Global In-vitro Toxicology Testing Market, for Skin Irritation Test,2018 - 2030, (USD Million)
Figure 29 Global In-vitro Toxicology Testing Market, for Skin Sensitization Test,2018 - 2030, (USD Million)
Figure 30 Global In-vitro Toxicology Testing Market, for Skin Corrosion Test,2018 - 2030, (USD Million)
Figure 31 Global In-vitro Toxicology Testing Market, for Phototoxicity Test,2018 - 2030, (USD Million)
Figure 32 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030, (USD Million)
Figure 33 Global In-vitro Toxicology Testing Market, for Endocrine Disruption,2018 - 2030, (USD Million)
Figure 34 Global In-vitro Toxicology Testing Market, for Dioxins,2018 - 2030, (USD Million)
Figure 35 Global In-vitro Toxicology Testing Market, for Phthalates,2018 - 2030, (USD Million)
Figure 36 Global In-vitro Toxicology Testing Market, for Polychlorinated biphenyls (PCB),2018 - 2030, (USD Million)
Figure 37 Global In-vitro Toxicology Testing Market, for Occular Toxicity,2018 - 2030, (USD Million)
Figure 38 Global In-vitro Toxicology Testing Market, for Intravitreal,2018 - 2030, (USD Million)
Figure 39 Global In-vitro Toxicology Testing Market, for Subretinal,2018 - 2030, (USD Million)
Figure 40 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030, (USD Million)
Figure 41 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030, (USD Million)
Figure 42 Global In-vitro Toxicology Testing Market, for Immunotoxicity,2018 - 2030, (USD Million)
Figure 43 Global In-vitro Toxicology Testing Market, for Reproductive Toxicity,2018 - 2030, (USD Million)
Figure 44 Global In-vitro Toxicology Testing Market, for Neurotoxicity,2018 - 2030, (USD Million)
Figure 45 Global In-vitro Toxicology Testing Market, for Epigenetic Alterations,2018 - 2030, (USD Million)
Figure 46 Global In-vitro Toxicology Testing Market, for Genotoxicity,2018 - 2030, (USD Million)
Figure 47 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030, (USD Million)
Figure 48 Global In-vitro Toxicology Testing Market, : Method Movement Analysis
Figure 49 Global In-vitro Toxicology Testing Market, for Cellular Assay,2018 - 2030, (USD Million)
Figure 50 Global In-vitro Toxicology Testing Market, for Live Cells,2018 - 2030, (USD Million)
Figure 51 Global In-vitro Toxicology Testing Market, for High Throughput / High Content Screening,2018 - 2030, (USD Million)
Figure 52 Global In-vitro Toxicology Testing Market, for Molecular Imaging,2018 - 2030, (USD Million)
Figure 53 Global In-vitro Toxicology Testing Market, for Confocal Microscopy,2018 - 2030, (USD Million)
Figure 54 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030, (USD Million)
Figure 55 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030, (USD Million)
Figure 56 Global In-vitro Toxicology Testing Market, for Fixed Cells,2018 - 2030, (USD Million)
Figure 57 Global In-vitro Toxicology Testing Market, for Biochemical Assay,2018 - 2030, (USD Million)
Figure 58 Global In-vitro Toxicology Testing Market, for In-silico ,2018 - 2030, (USD Million)
Figure 59 Global In-vitro Toxicology Testing Market, for Ex-vivo,2018 - 2030, (USD Million)
Figure 60 Global In-vitro Toxicology Testing Market: Technology Movement Analysis
Figure 61 Global In-vitro Toxicology Testing Market, for Cell Culture Technology,2018 - 2030, (USD Million)
Figure 62 Global In-vitro Toxicology Testing Market, for High Throughput Technology,2018 - 2030, (USD Million)
Figure 63 Global In-vitro Toxicology Testing Market, for Molecular Imaging,2018 - 2030, (USD Million)
Figure 64 Global In-vitro Toxicology Testing Market, for OMICS Technology,2018 - 2030, (USD Million)
Figure 65 Global In-vitro Toxicology Testing Market: End-Use Movement Analysis
Figure 66 Global In-vitro Toxicology Testing Market, for Pharmaceutical Industry,2018 - 2030, (USD Million)
Figure 67 Global In-vitro Toxicology Testing Market, for Cosmetics & Household Products,2018 - 2030, (USD Million)
Figure 68 Global In-vitro Toxicology Testing Market, for Academic Institutes & Research Laboratories,2018 - 2030, (USD Million)
Figure 69 Global In-vitro Toxicology Testing Market, for Diagnostics,2018 - 2030, (USD Million)
Figure 70 Global In-vitro Toxicology Testing Market, for Medical Devices,2018 - 2030, (USD Million)
Figure 71 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030, (USD Million)
Figure 72 Global In-vitro Toxicology Testing Market, for Chemicals Industry,2018 - 2030, (USD Million)
Figure 73 Global In-vitro Toxicology Testing Market, for Food Industry ,2018 - 2030, (USD Million)
Figure 74 Regional Marketplace: Key Takeaways
Figure 75 Regional Outlook, 2023 & 2030
Figure 76 Global In-vitro Toxicology Testing Market: Region Movement Analysis
Figure 77 North America In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 78 U.S. In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 79 Canada In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 80 Europe In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 81 Germany In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 82 UK In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 83 France In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 84 Italy In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 85 Spain In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 86 Sweden In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 87 Denmark In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 88 Norway In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 89 Asia Pacific In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 90 Japan In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 91 China In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 92 India In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 93 Australia In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 94 South Korea In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 95 Thailand In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 96 Latin America In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 97 Brazil In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 98 Mexico In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 99 Argentina In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 100 Middle East and Africa In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 101 South Africa In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 102 Saudi Arabia In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 103 UAE In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)
Figure 104 Kuwait In-vitro Toxicology Testing Market, 2018 - 2030, (USD Million)

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email